1. On March 25, 2008, OTI received a warning letter in connection with a FDA
    inspection of OTI's facilities in July and August of 2007. The warning letter
    cited several deficiencies in OTI's quality, record keeping, and reporting
    systems relating to certain of OTI's products, including the OTI Scan 1000, OTI
    Scan 2000, and OTI OCT/SLO combination imaging system. Based upon the
    observations noted in the warning letter, OTI is not currently in compliance
    with cGMP. The FDA indicated that it has issued an Import Alert and may refuse
    admission of these products. ... (Read Full Article)

    Related Articles

Login to comment.

 
Home All Articles Entities Quotes Comments Login Register Powered by HiveFire